Bharat Parenter.

{
  "main_header": {
    "sid": 1002949,
    "name": "Bharat Parenter.",
    "stock_name": "Bharat Parenter.",
    "full_name": "Bharat Parenterals Ltd",
    "name_url": "stocks-analysis/bharat-parenter",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,380.00",
    "chg": -18.2,
    "chgp": "-1.3%",
    "dir": -1,
    "prev_price": "1,398.20",
    "mcapval": "964.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541096,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE365Y01019",
    "curr_date": "Jun 04, 03:30 PM",
    "curr_time": "02:00 AM",
    "last_traded_at": "Jun 04, 03:30 PM IST",
    "bse_nse_vol": 1300,
    "exc_status": "Active",
    "traded_date": "Jun 04, 2026",
    "traded_date_str": "2026 06 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-parenter-1002949-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Parenterals Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4035471",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BharatParentera_mojoScore_4035471.png",
        "date": "2026-06-04 08:31:23",
        "description": "Bharat Parenterals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 3 June 2026, driven primarily by a marked improvement in technical indicators despite ongoing financial headwinds. The pharmaceutical micro-cap’s recent price momentum and bullish technical signals contrast with its weak fundamental performance, presenting a nuanced outlook for investors."
      },
      {
        "title": "Bharat Parenterals Ltd Sees Bullish Momentum Amid Technical Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-sees-bullish-momentum-amid-technical-shift-4035305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BharatParentera_technicaldot_4035305.png",
        "date": "2026-06-04 08:04:58",
        "description": "Bharat Parenterals Ltd has demonstrated a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. The stock’s recent 7.01% daily gain to ₹1,398.20, coupled with positive weekly MACD and Bollinger Bands signals, suggests renewed investor interest despite a micro-cap classification and a cautious MarketsMOJO Mojo Grade of Sell."
      },
      {
        "title": "Bharat Parenterals Ltd Forms Golden Cross Amid Mixed Technical Signals and Strong Recent Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4034450",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BharatParentera_goldencross_4034450.png",
        "date": "2026-06-03 18:00:54",
        "description": "The 50-day moving average for Bharat Parenterals Ltd has crossed above the 200-day moving average, signalling a golden cross on 3 June 2026. Yet, this technical milestone arrives amid a complex backdrop of mixed momentum indicators and a micro-cap status, raising questions about the signal’s reliability in isolation."
      },
      {
        "title": "Bharat Parenterals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-is-rated-strong-sell-4013498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_mojoScore_4013498.png",
        "date": "2026-05-26 10:10:29",
        "description": "Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial data presented here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4012738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_technicaldot_4012738.png",
        "date": "2026-05-26 08:06:38",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade to a Strong Sell rating, the stock’s price action and technical indicators reveal a nuanced picture that investors should carefully analyse."
      },
      {
        "title": "Bharat Parenterals Gains 10.53%: 2 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-gains-1053-2-key-factors-driving-the-weeks-momentum-4008185",
        "imagepath": "",
        "date": "2026-05-23 13:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock closes at Rs.1,266.55 with mixed technical signals amid mildly bullish momentum</p>\n                    <p><strong>19 May:</strong> Q4 FY26 results reveal mounting losses and operational turmoil</p>\n                    <p><strong>21 May:</strong> Sharp price jump to Rs.1,320.90 (+5.20%) on improving technical outlook</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.1,383.95 (+4.77%), outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,252.05</div></div>\n                    <div class=\"stat-it..."
      },
      {
        "title": "Are Bharat Parenterals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bharat-parenterals-ltd-latest-results-good-or-bad-3999564",
        "imagepath": "",
        "date": "2026-05-19 19:21:30",
        "description": "Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. \n\nNet sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector.\n\nThe operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres..."
      },
      {
        "title": "Bharat Parenterals Q4 FY26: Mounting Losses and Operational Turmoil Signal Deeper Structural Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/bharat-parenterals-q4-fy26-mounting-losses-and-operational-turmoil-signal-deeper-structural-crisis-3999105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_quaterlyResult_3999105.png",
        "date": "2026-05-19 09:51:31",
        "description": "Bharat Parenterals Ltd., a Gujarat-based pharmaceutical manufacturer, reported a consolidated net loss of ₹4.80 crores for Q4 FY26 ended March 2026, extending a troubling pattern of persistent losses across the fiscal year. The micro-cap company, with a market capitalisation of ₹845.99 crores, saw its stock decline 3.08% to ₹1,227.50 following the results announcement, reflecting investor concern over deteriorating operational metrics and negative operating margins."
      },
      {
        "title": "Bharat Parenterals Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-shows-mixed-technical-signals-amid-mildly-bullish-momentum-3996137",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_technicaldot_3996137.png",
        "date": "2026-05-18 08:02:59",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors amid recent price gains and sector dynamics."
      }
    ],
    "total": 425,
    "sid": "1002949",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-parenterals-1002949"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Jun-2026",
      "details": "Please find the enclosed newspaper notice to the physical Shareholders informing them about the special Window for re lodge the transfer deed.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Annual Secretarial Compliance report for the Year ended March 31 2026 Pursuant to regulations 24A of SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-May-2026",
      "details": "Newspaper publication of Audited Financial Results of the Quarter and Year ended on March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bharat Parenterals Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bharat Parenterals Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-06-04 08:31:23

Bharat Parenterals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 3 June 2026, driven primarily by a marked improvement in technical indicators despite ongoing financial headwinds. The pharmaceutical micro-cap’s recent price momentum and bullish technical signals contrast with its weak fundamental performance, presenting a nuanced outlook for investors.

Read full news article

Bharat Parenterals Ltd Sees Bullish Momentum Amid Technical Shift

2026-06-04 08:04:58

Bharat Parenterals Ltd has demonstrated a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. The stock’s recent 7.01% daily gain to ₹1,398.20, coupled with positive weekly MACD and Bollinger Bands signals, suggests renewed investor interest despite a micro-cap classification and a cautious MarketsMOJO Mojo Grade of Sell.

Read full news article

Bharat Parenterals Ltd Forms Golden Cross Amid Mixed Technical Signals and Strong Recent Rally

2026-06-03 18:00:54

The 50-day moving average for Bharat Parenterals Ltd has crossed above the 200-day moving average, signalling a golden cross on 3 June 2026. Yet, this technical milestone arrives amid a complex backdrop of mixed momentum indicators and a micro-cap status, raising questions about the signal’s reliability in isolation.

Read full news article

Bharat Parenterals Ltd is Rated Strong Sell

2026-05-26 10:10:29

Bharat Parenterals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial data presented here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-26 08:06:38

Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade to a Strong Sell rating, the stock’s price action and technical indicators reveal a nuanced picture that investors should carefully analyse.

Read full news article

Bharat Parenterals Gains 10.53%: 2 Key Factors Driving the Week’s Momentum

2026-05-23 13:00:04

Key Events This Week

18 May: Stock closes at Rs.1,266.55 with mixed technical signals amid mildly bullish momentum

19 May: Q4 FY26 results reveal mounting losses and operational turmoil

21 May: Sharp price jump to Rs.1,320.90 (+5.20%) on improving technical outlook

22 May: Week closes at Rs.1,383.95 (+4.77%), outperforming Sensex

Week Open

Rs.1,252.05

Read full news article

Are Bharat Parenterals Ltd latest results good or bad?

2026-05-19 19:21:30

Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. Net sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector. The operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres...

Read full news article

Bharat Parenterals Q4 FY26: Mounting Losses and Operational Turmoil Signal Deeper Structural Crisis

2026-05-19 09:51:31

Bharat Parenterals Ltd., a Gujarat-based pharmaceutical manufacturer, reported a consolidated net loss of ₹4.80 crores for Q4 FY26 ended March 2026, extending a troubling pattern of persistent losses across the fiscal year. The micro-cap company, with a market capitalisation of ₹845.99 crores, saw its stock decline 3.08% to ₹1,227.50 following the results announcement, reflecting investor concern over deteriorating operational metrics and negative operating margins.

Read full news article

Bharat Parenterals Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum

2026-05-18 08:02:59

Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors amid recent price gains and sector dynamics.

Read full news article

View All News